The silent spiral
Every month, millions of women are handed a prescription and rarely a warning.
Oral contraceptive pills are prescribed for contraception, acne, PCOS, endometriosis and more. Versatile, yes. But not without consequence.
Studies, including a landmark Danish cohort study (Skovlund et al., JAMA Psychiatry, 2016) tracking over one million women, found a significantly increased risk of depression and antidepressant use among OCP users particularly adolescents. Anxiety, emotional blunting, mood instability, and in severe cases, suicidal ideation, have all been documented as associated complications. These are not rare footnotes. They are patterns. 
Why this deserves serious attention? 
Hormonal contraceptives directly influence serotonin and dopamine pathways the very systems that regulate mood and emotional resilience. When these are disrupted, the psychological fallout can be profound, yet it frequently goes undiagnosed or misattributed.
The normalisation problem
- “Everyone feels a bit low on the pill.”
- “Your mood will settle.”
- “It’s just hormones.”
That’s not medicine. That’s dismissal. 
Research increasingly points toward a few simple shifts that may make a significant difference:
Baseline mood screening before initiating OCPs: particularly in younger patients or those with prior mental health history (Skovlund et al., 2016)
Progestin type matters: evidence suggests certain progestins are associated with lower psychiatric risk than others, making formulation choice clinically meaningful (Poromaa & Segebladh, 2012)
Follow-up within the first 3 months the period when mood-related side effects are most likely to emerge
Documented informed consent that includes psychiatric side effects alongside physical ones
Not as a challenge to clinical judgment but as an addition to it. 
MBH/PS